Sample Answer for NURS 6521 DECISION TREE FOR NEUROLOGICAL AND MUSCULOSKELETAL Included After Question<\/strong><\/span><\/h2>\n NURS 6521 DECISION TREE FOR NEUROLOGICAL AND MUSCULOSKELETAL<\/strong><\/p>\nDECISION TREE FOR NEUROLOGICAL AND MUSCULOSKELETAL<\/span>\u00a0<\/span><\/a><\/p>\nRESOURCES<\/span>\u00a0<\/span><\/p>\nBe sure to review the Learning Resources before completing this activity.<\/span>
\nClick the weekly resources link to access the resources.\u202f<\/span>\u00a0<\/span><\/p>\nWEEKLY RESOURCES<\/span><\/b><\/a>\u00a0<\/span><\/p>\n![\"NURS](\"http:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2024\/02\/Capture-8-3-300x66.png\")
NURS 6521 DECISION TREE FOR NEUROLOGICAL AND MUSCULOSKELETAL<\/figcaption><\/figure>\nBY DAY 7 OF WEEK 8<\/span>\u00a0<\/span><\/h2>\nSubmit\u202f<\/span><\/b>your Assignment, started in Week 6.<\/span>\u00a0<\/span><\/p>\nReminder:<\/span><\/b>\u202fThe College of Nursing requires that all papers submitted include a title page, introduction, summary, and references. The Sample Paper provided at the Walden Writing Center offers an example of those required elements (available at\u202f<\/span>http:\/\/writingcenter.waldenu.edu\/57.htm\u202fLinks to an external site.<\/span><\/a>). All papers submitted must use this formatting.<\/span>\u00a0<\/span><\/p>\nSUBMISSION INFORMATION<\/span>\u00a0<\/span><\/p>\nBefore submitting your final assignment, you can check your draft for authenticity. To check your draft, access the\u202f<\/span>Turnitin Drafts<\/span><\/b>\u202ffrom the\u202f<\/span>Start Here<\/span><\/b>\u202farea.\u202f<\/span>\u00a0<\/span><\/p>\n\n- To submit your completed assignment, save your Assignment as\u202f<\/span>WK8Assgn_LastName_Firstinitial<\/span><\/b>\u00a0<\/span><\/li>\n<\/ol>\n
\n- Then, click on\u202f<\/span>Start Assignment<\/span><\/b>\u202fnear the top of the page.<\/span>\u00a0<\/span><\/li>\n<\/ol>\n
\n- Next, click on\u202f<\/span>Upload File<\/span><\/b>\u202fand select\u202f<\/span>Submit Assignment<\/span><\/b>\u202ffor review.<\/span>\u00a0<\/span><\/li>\n<\/ol>\n
A Sample Answer For the Assignment: NURS 6521 DECISION TREE FOR NEUROLOGICAL AND MUSCULOSKELETAL<\/strong><\/h2>\nTitle: NURS 6521 DECISION TREE FOR NEUROLOGICAL AND MUSCULOSKELETAL<\/strong><\/h2>\nIntegrating Evidence-Based Practices in Complex Pain Management: A Case Study Analysis<\/span><\/b>\u00a0<\/span><\/h3>\nIntroduction<\/span><\/b>\u00a0<\/span><\/h4>\nComplex Regional Pain Syndrome (CRPS), a challenging neurological condition, demands a nuanced and evidence-based approach to alleviate suffering and enhance patients’ quality of life. This in-depth analysis delves into the intricate case of a 43-year-old white male diagnosed with CRPS in his right hip. Through a series of carefully considered decisions, this patient’s journey sheds light on the complexities of managing CRPS while balancing medication side effects and therapeutic outcomes.<\/span>\u00a0<\/span><\/p>\nPatient Summary<\/span><\/b>\u00a0<\/span><\/h2>\nThe patient’s ordeal commenced seven years ago, following a fall at work resulting in significant right hip injury. Despite extensive diagnostic tests, he faced skepticism from healthcare professionals, leading to delays in appropriate treatment. The decisions taken included initiating amitriptyline at 25 mg, titrating to 125 mg at bedtime, and later reducing the dosage to 100 mg daily. These decisions were geared towards mitigating pain, enhancing functionality, and minimizing side effects such as grogginess and weight gain.<\/span>\u00a0<\/span><\/p>\nEvidence-Based Support for Decisions<\/span><\/b>\u00a0<\/span><\/h2>\nThe initiation of amitriptyline aligns with studies demonstrating its efficacy in managing neuropathic pain, particularly CRPS (Neyama et al., 2020). Amitriptyline, a tricyclic antidepressant, modulates pain perception through multiple pathways, making it a cornerstone in neuropathic pain management (Solomon et al., 2022). The decision to maintain the dose despite minor weight gain is substantiated by research indicating that the benefits of pain control often outweigh modest side effects (Naguib et al., 2021). Additionally, the avoidance of Qsymia was prudent, considering its potential cardiac risks and the patient’s BMI falling below the recommended threshold for its use (Lei et al., 2021).<\/span>\u00a0<\/span><\/p>\nIn addition to pharmaceutical interventions, exploring alternative therapies such as neuromodulation techniques has gained significant attention. A comprehensive study by Sivanesan, & Goebel (2021) delves into the effectiveness of spinal cord stimulation and peripheral nerve stimulation in managing Complex Regional Pain Syndrome, providing valuable insights into diverse treatment modalities.\u00a0<\/span>\u00a0<\/span><\/p>\nGoals and Outcomes<\/span><\/b>\u00a0<\/span><\/h2>\nThe overarching goal was to reduce the patient’s pain levels to an acceptable threshold (around 3 on the scale) and restore his ability to perform daily activities without crutches. The outcomes were remarkably positive; the patient’s pain diminished from a debilitating 9 to a manageable 4. This reduction facilitated enhanced mobility and daily functioning, marking a significant improvement in his overall well-being. Despite minor weight gain, the patient’s improved quality of life underscored the success of the interventions.<\/span>\u00a0<\/span><\/p>\nDiscrepancies Between Expectations and Results<\/span><\/b>\u00a0<\/span><\/h2>\nIn this case, the outcomes closely mirrored the expectations. The patient experienced a substantial reduction in pain, improved functionality, and minimal side effects, including manageable weight gain. The decisions made successfully struck a delicate balance between therapeutic benefits and potential drawbacks, ensuring the patient’s optimal quality of life. The minor weight gain, while a concern, was overshadowed by the vast improvements in pain control and functionality, aligning with the patient’s stated preferences.<\/span>\u00a0<\/span><\/p>\nConclusion<\/span><\/b>\u00a0<\/span><\/h2>\nCRPS management necessitates a holistic and individualized approach, integrating evidence-based practices, patient preferences, and vigilant monitoring of outcomes. This case study underscores the pivotal role of healthcare providers in navigating the complexities of CRPS treatment. By employing a comprehensive understanding of available therapies and their potential effects, clinicians can significantly enhance the lives of individuals afflicted with this debilitating condition.<\/span>\u00a0<\/span><\/p>\n\u00a0<\/span><\/p>\nReferences<\/span><\/b>\u00a0<\/span><\/h2>\nLei, X., Ruan, J., Lai, C., Sun, Z., Yang, X., Lei, X.-G., & Ruan, J.-Q. (2021). Efficacy and Safety of Phentermine\/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis.\u202f<\/span>Obesity (19307381)<\/span><\/i>,\u202f<\/span>29<\/span><\/i>(6), 985\u2013994. <\/span>https:\/\/doi.org\/10.1002\/oby.23152<\/span><\/a>\u00a0<\/span><\/p>\nNaguib, I. A., Ali, N. A., Elroby, F. A., & Elghobashy, M. R. (2021). Green HPLC-DAD and HPTLC Methods for Quantitative Determination of Binary Mixture of Pregabalin and Amitriptyline Used for Neuropathic Pain Management.\u202f<\/span>Journal of Chromatographic Science<\/span><\/i>,\u202f<\/span>59<\/span><\/i>(6), 536\u2013547. <\/span>https:\/\/doi.org\/10.1093\/chromsci\/bmab031<\/span><\/a>\u00a0<\/span><\/p>\nNeyama, H., Dozono, N., Uchida, H., & Ueda, H. (2020). Mirtazapine, an \u03b1 2 Antagonist-Type Antidepressant, Reverses Pain and Lack of Morphine Analgesia in Fibromyalgia-Like Mouse Models.\u202f<\/span>The Journal of Pharmacology and Experimental Therapeutics<\/span><\/i>,\u202f<\/span>375<\/span><\/i>(1), 1\u20139. <\/span>https:\/\/doi.org\/10.1124\/jpet.120.265942<\/span><\/a>\u00a0<\/span><\/p>\nSivanesan, E., & Goebel, A. (2021). Complex regional pain syndrome: developing diagnostic tools and treatments from sympathetic nervous system, neuroimmune and neuromodulation discoveries in neuropathic pain.\u202f<\/span>Regional Anesthesia & Pain Medicine<\/span><\/i>,\u202f<\/span>46<\/span><\/i>(3), 193\u2013195. <\/span>https:\/\/doi.org\/10.1136\/rapm-2020-101644<\/span><\/a>\u00a0<\/span><\/p>\n
DECISION TREE FOR NEUROLOGICAL AND MUSCULOSKELETAL<\/span>\u00a0<\/span><\/a><\/p>\n RESOURCES<\/span>\u00a0<\/span><\/p>\n Be sure to review the Learning Resources before completing this activity.<\/span> WEEKLY RESOURCES<\/span><\/b><\/a>\u00a0<\/span><\/p>\n Submit\u202f<\/span><\/b>your Assignment, started in Week 6.<\/span>\u00a0<\/span><\/p>\n Reminder:<\/span><\/b>\u202fThe College of Nursing requires that all papers submitted include a title page, introduction, summary, and references. The Sample Paper provided at the Walden Writing Center offers an example of those required elements (available at\u202f<\/span>http:\/\/writingcenter.waldenu.edu\/57.htm\u202fLinks to an external site.<\/span><\/a>). All papers submitted must use this formatting.<\/span>\u00a0<\/span><\/p>\n SUBMISSION INFORMATION<\/span>\u00a0<\/span><\/p>\n Before submitting your final assignment, you can check your draft for authenticity. To check your draft, access the\u202f<\/span>Turnitin Drafts<\/span><\/b>\u202ffrom the\u202f<\/span>Start Here<\/span><\/b>\u202farea.\u202f<\/span>\u00a0<\/span><\/p>\n Complex Regional Pain Syndrome (CRPS), a challenging neurological condition, demands a nuanced and evidence-based approach to alleviate suffering and enhance patients’ quality of life. This in-depth analysis delves into the intricate case of a 43-year-old white male diagnosed with CRPS in his right hip. Through a series of carefully considered decisions, this patient’s journey sheds light on the complexities of managing CRPS while balancing medication side effects and therapeutic outcomes.<\/span>\u00a0<\/span><\/p>\n The patient’s ordeal commenced seven years ago, following a fall at work resulting in significant right hip injury. Despite extensive diagnostic tests, he faced skepticism from healthcare professionals, leading to delays in appropriate treatment. The decisions taken included initiating amitriptyline at 25 mg, titrating to 125 mg at bedtime, and later reducing the dosage to 100 mg daily. These decisions were geared towards mitigating pain, enhancing functionality, and minimizing side effects such as grogginess and weight gain.<\/span>\u00a0<\/span><\/p>\n The initiation of amitriptyline aligns with studies demonstrating its efficacy in managing neuropathic pain, particularly CRPS (Neyama et al., 2020). Amitriptyline, a tricyclic antidepressant, modulates pain perception through multiple pathways, making it a cornerstone in neuropathic pain management (Solomon et al., 2022). The decision to maintain the dose despite minor weight gain is substantiated by research indicating that the benefits of pain control often outweigh modest side effects (Naguib et al., 2021). Additionally, the avoidance of Qsymia was prudent, considering its potential cardiac risks and the patient’s BMI falling below the recommended threshold for its use (Lei et al., 2021).<\/span>\u00a0<\/span><\/p>\n In addition to pharmaceutical interventions, exploring alternative therapies such as neuromodulation techniques has gained significant attention. A comprehensive study by Sivanesan, & Goebel (2021) delves into the effectiveness of spinal cord stimulation and peripheral nerve stimulation in managing Complex Regional Pain Syndrome, providing valuable insights into diverse treatment modalities.\u00a0<\/span>\u00a0<\/span><\/p>\n The overarching goal was to reduce the patient’s pain levels to an acceptable threshold (around 3 on the scale) and restore his ability to perform daily activities without crutches. The outcomes were remarkably positive; the patient’s pain diminished from a debilitating 9 to a manageable 4. This reduction facilitated enhanced mobility and daily functioning, marking a significant improvement in his overall well-being. Despite minor weight gain, the patient’s improved quality of life underscored the success of the interventions.<\/span>\u00a0<\/span><\/p>\n In this case, the outcomes closely mirrored the expectations. The patient experienced a substantial reduction in pain, improved functionality, and minimal side effects, including manageable weight gain. The decisions made successfully struck a delicate balance between therapeutic benefits and potential drawbacks, ensuring the patient’s optimal quality of life. The minor weight gain, while a concern, was overshadowed by the vast improvements in pain control and functionality, aligning with the patient’s stated preferences.<\/span>\u00a0<\/span><\/p>\n CRPS management necessitates a holistic and individualized approach, integrating evidence-based practices, patient preferences, and vigilant monitoring of outcomes. This case study underscores the pivotal role of healthcare providers in navigating the complexities of CRPS treatment. By employing a comprehensive understanding of available therapies and their potential effects, clinicians can significantly enhance the lives of individuals afflicted with this debilitating condition.<\/span>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n Lei, X., Ruan, J., Lai, C., Sun, Z., Yang, X., Lei, X.-G., & Ruan, J.-Q. (2021). Efficacy and Safety of Phentermine\/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis.\u202f<\/span>Obesity (19307381)<\/span><\/i>,\u202f<\/span>29<\/span><\/i>(6), 985\u2013994. <\/span>https:\/\/doi.org\/10.1002\/oby.23152<\/span><\/a>\u00a0<\/span><\/p>\n Naguib, I. A., Ali, N. A., Elroby, F. A., & Elghobashy, M. R. (2021). Green HPLC-DAD and HPTLC Methods for Quantitative Determination of Binary Mixture of Pregabalin and Amitriptyline Used for Neuropathic Pain Management.\u202f<\/span>Journal of Chromatographic Science<\/span><\/i>,\u202f<\/span>59<\/span><\/i>(6), 536\u2013547. <\/span>https:\/\/doi.org\/10.1093\/chromsci\/bmab031<\/span><\/a>\u00a0<\/span><\/p>\n Neyama, H., Dozono, N., Uchida, H., & Ueda, H. (2020). Mirtazapine, an \u03b1 2 Antagonist-Type Antidepressant, Reverses Pain and Lack of Morphine Analgesia in Fibromyalgia-Like Mouse Models.\u202f<\/span>The Journal of Pharmacology and Experimental Therapeutics<\/span><\/i>,\u202f<\/span>375<\/span><\/i>(1), 1\u20139. <\/span>https:\/\/doi.org\/10.1124\/jpet.120.265942<\/span><\/a>\u00a0<\/span><\/p>\n Sivanesan, E., & Goebel, A. (2021). Complex regional pain syndrome: developing diagnostic tools and treatments from sympathetic nervous system, neuroimmune and neuromodulation discoveries in neuropathic pain.\u202f<\/span>Regional Anesthesia & Pain Medicine<\/span><\/i>,\u202f<\/span>46<\/span><\/i>(3), 193\u2013195. <\/span>https:\/\/doi.org\/10.1136\/rapm-2020-101644<\/span><\/a>\u00a0<\/span><\/p>\n
\nClick the weekly resources link to access the resources.\u202f<\/span>\u00a0<\/span><\/p>\nBY DAY 7 OF WEEK 8<\/span>\u00a0<\/span><\/h2>\n
\n
\n
\n
A Sample Answer For the Assignment: NURS 6521 DECISION TREE FOR NEUROLOGICAL AND MUSCULOSKELETAL<\/strong><\/h2>\n
Title: NURS 6521 DECISION TREE FOR NEUROLOGICAL AND MUSCULOSKELETAL<\/strong><\/h2>\n
Integrating Evidence-Based Practices in Complex Pain Management: A Case Study Analysis<\/span><\/b>\u00a0<\/span><\/h3>\n
Introduction<\/span><\/b>\u00a0<\/span><\/h4>\n
Patient Summary<\/span><\/b>\u00a0<\/span><\/h2>\n
Evidence-Based Support for Decisions<\/span><\/b>\u00a0<\/span><\/h2>\n
Goals and Outcomes<\/span><\/b>\u00a0<\/span><\/h2>\n
Discrepancies Between Expectations and Results<\/span><\/b>\u00a0<\/span><\/h2>\n
Conclusion<\/span><\/b>\u00a0<\/span><\/h2>\n
References<\/span><\/b>\u00a0<\/span><\/h2>\n